Nivolumab-associated cutaneous T-cell lymphoma.

Marks, Jennifer A; Parker, Douglas C; Garrot, L Crain; Lechowicz, Mary Jo

Marks, Jennifer A; Parker, Douglas C; Garrot, L Crain; Lechowicz, Mary Jo.

Afiliación

Marks JA; Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia.
Parker DC; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
Garrot LC; Georgia Cancer Specialists, Northside Hospital Cancer Institute, Atlanta, Georgia.
Lechowicz MJ; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

JAAD Case Rep ; 9: 39-41, 2021 Mar.

Article en En | MEDLINE | ID: mdl-33644277

Palabras clave

CTCL; CTCL, cutaneous T-cell lymphoma; RCC, renal cell carcinoma; Sezary syndrome; adverse events; immune checkpoint inhibitor; mycosis fungoides; nivolumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: JAAD Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Georgia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google